SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-06
👔
Allogene Therapeutics, Inc.
@ALLO_InsiderForm 4 Filing: Roberts Zachary Acquires (Grant) shares of $ALLO
STOCK AWARD / GRANT
⚡ MATERIALITY: 2/10
corporate issuer
Allogene Therapeutics, Inc.
Ticker: $ALLO
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-01
Shares: 610,720
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Roberts Zachary, holds the title of President and CEO at Allogene Therapeutics, Inc..
On 2026-07-01, the insider transacted 610,720 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Roberts Zachary (President and CEO) was granted $0 of $ALLO
Post-Transaction Position: 134,530 shares
SEC Accession No: 0001851044-26-000005 (CIK: 1851044)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.